Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Receivables: 2009-2024

Historic Change in Receivables for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to -$3.4 million.

  • Anika Therapeutics' Change in Receivables rose 72.92% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 123.83%. This contributed to the annual value of -$3.4 million for FY2024, which is 357.93% down from last year.
  • Anika Therapeutics' Change in Receivables amounted to -$3.4 million in FY2024, which was down 357.93% from $1.3 million recorded in FY2023.
  • Over the past 5 years, Anika Therapeutics' Change in Receivables peaked at $6.2 million during FY2021, and registered a low of -$5.9 million during FY2020.
  • Over the past 3 years, Anika Therapeutics' median Change in Receivables value was $1.3 million (recorded in 2023), while the average stood at $1.2 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 418.38% in 2020, then surged by 206.17% in 2021.
  • Anika Therapeutics' Change in Receivables (MRY) stood at -$5.9 million in 2020, then surged by 206.17% to $6.2 million in 2021, then fell by 9.43% to $5.6 million in 2022, then crashed by 76.82% to $1.3 million in 2023, then tumbled by 357.93% to -$3.4 million in 2024.
  • Its Change in Receivables was -$3.4 million in FY2024, compared to $1.3 million in FY2023 and $5.6 million in FY2022.